Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Elife|July 28, 2021
Association of human breast cancer CD44-/CD24- cells with delayed distant metastasisXinbo Qiao, Yixiao Zhang, Lisha Sun, et al.ACS Energy Letters|February 19, 2026
Continuous Ammonia Electrosynthesis from Nitrogen and Water in a Monolithic Pd Membrane-Based Flow CellBoxi Ye, Craig Burdis, Vladislav Mints, et al.Frontiers in Oncology|September 9, 2024
Prospective nutrition-inflammation markers for predicting early stoma-related complications in patients with colorectal cancer undergoing enterostomyJie Yuan, Fan Jiang, Xiaochao Fu, et al.Oncotarget|November 8, 2017
Predicting level 2 axillary lymph node metastasis in a Chinese breast cancer population post-neoadjuvant chemotherapy: development and assessment of a new predictive nomogramCaigang Liu, Yanlin Jiang, Xin Gu, et al.Journal of Experimental Botany|December 12, 2018
Overexpression of rice aquaporin OsPIP1;2 improves yield by enhancing mesophyll CO2 conductance and phloem sucrose transportFeiyun Xu, Ke Wang, Wei Yuan, et al.Plos One|July 22, 2015
Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant ChemotherapyZining Jin, Wenqian Wang, Nan Jiang, et al.Nature Communications|May 5, 2023
KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancerJiawen Bu, Yixiao Zhang, Sijin Wu, et al.Cancer Letters|December 17, 2008
CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinomaLijie He, Hanmin Wang, Haifeng Jin, et al.Elife|March 14, 2022
Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancerYixiao Zhang, Lisha Sun, Haonan Li, et al.Science China. Life Sciences|July 17, 2023
FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathwayGuanglei Chen, Lisha Sun, Xi Gu, et al.Pageof 8